Patent directory · USPTO A61K / A61P
Patents matching “Aurigene Discovery Technologies Limited”
42 pharma patents match "Aurigene Discovery Technologies Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 42 pharmaceutical patents matching "Aurigene Discovery Technologies Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10106581
Cyclic peptidomimetic compounds as immunomodulators
granted -
US 10080740
Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted -
US 10047104
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 9937155
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted -
US 9783578
Immunosuppression modulating compounds
granted -
US 9776978
1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
granted -
US 9732095
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 9630932
Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted -
US 9422339
Immunomodulating cyclic compounds
granted -
US 9353107
3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors
granted -
US 9233940
Cyclic peptidomimetic compounds as immunomodulators
granted -
US 9096642
Therapeutic compounds for immunomodulation
granted -
US 9062075
Tetrahydropyridine derivatives as FabI inhibitors
granted -
US 9062002
Substituted pyridine derivatives as FabI inhibitors
granted -
US 9044442
Peptidomimetic compounds as immunomodulators
granted -
US 8962637
Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors
granted -
US 8907053
Immunosuppression modulating compounds
granted -
US 8440679
Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors
granted